MiMedx Group, Inc.
- MDXG
- NASDAQ
- Biotechnology
- Regenerative Medicine
- Placental Allografts
$4.38
Today −1.24%Quote Oct 19, 2026, 05:00 PM UTC
−5.54%over the last month
Max drawdown −10.1%From 1-month high −10.1%3 months +2.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About MiMedx
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
808
Market value
$637.7M
Quote Oct 19
Floor
$4.35
0.6% below price
Resistance
$4.38
0.2% above price
Price vs analyst targets
15 analysts
Lowest target
$7.00Highest target
$8.00
$7.00Highest target
$8.00
- Price $4.38
- Average target $7.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 75% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MDXGPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free